Influence of hyperinsulinemia, hyperglycemia, and the route of glucose administration on splanchnic glucose exchange - PubMed (original) (raw)

Influence of hyperinsulinemia, hyperglycemia, and the route of glucose administration on splanchnic glucose exchange

R A DeFronzo et al. Proc Natl Acad Sci U S A. 1978 Oct.

Abstract

The effects of hyperinsulinemia, hyperglycemia, and the route of glucose administration on total glucose utilization and on net splanchnic glucose exchange were studied in 20 normal volunteers with the hepatic venous catheter technique. Euglycemic hyperinsulinemia [induced by a priming plus continuous infusion of insulin resulting in plasma insulin levels of 400-1200 muunits (international)/ml and a variable glucose infusion] caused a 5- to 6-fold increase above basal in total glucose turnover. However, net splanchnic glucose uptake (0.5 +/- 0.2 mg/kg per min) accounted for only 4-5% of total glucose utilization. When hyperglycemia (223 +/- 1 mg/dl) was induced in addition to hyperinsulinemia by the intravenous infusion of glucose, splanchnic glucose uptake increased 100% to 1.0-1.1 mg/kg per min but was still responsible for only 10-14% of total glucose utilization. In other studies hyperglycemia (223 +/- 2 mg/dl) was maintained constant by a variable intravenous infusion of glucose for 4 hr and oral glucose (1.2 gm/kg) was administered at 1 hr. After the oral glucose, net splanchnic glucose uptake increased to values 6-fold higher than with intravenous glucose despite unchanged plasma glucose levels and plasma insulin concentrations well below those observed in the studies with euglycemic hyperinsulinemia. The results indicate that hyperinsulinemia or hyperglycemia induced by intravenous infusion of glucose or insulin causes minimal net uptake of glucose by the splanchnic bed despite marked stimulation of total glucose turnover. In contrast, administration of glucose by the oral route has a marked stimulatory effect on net splanchnic glucose uptake. These findings suggest that orally consumed glucose causes the release of a gastrointestinal factor that enhances insulin-mediated glucose uptake by the liver.

PubMed Disclaimer

Cited by

Possible mechanism by which somatostatin-induced glucagon suppression improves glucose tolerance during insulinopaenia in man.
Liljenquist JE, Bloomgarden ZT, Cherrington AD, Perry JM, Rabin D. Liljenquist JE, et al. Diabetologia. 1979 Sep;17(3):139-43. doi: 10.1007/BF01219739. Diabetologia. 1979. PMID: 510828 No abstract available.
Short-term dietary reduction of branched-chain amino acids reduces meal-induced insulin secretion and modifies microbiome composition in type 2 diabetes: a randomized controlled crossover trial.
Karusheva Y, Koessler T, Strassburger K, Markgraf D, Mastrototaro L, Jelenik T, Simon MC, Pesta D, Zaharia OP, Bódis K, Bärenz F, Schmoll D, Wolkersdorfer M, Tura A, Pacini G, Burkart V, Müssig K, Szendroedi J, Roden M. Karusheva Y, et al. Am J Clin Nutr. 2019 Nov 1;110(5):1098-1107. doi: 10.1093/ajcn/nqz191. Am J Clin Nutr. 2019. PMID: 31667519 Free PMC article. Clinical Trial.
Influence of hyperglycemia on insulin's in vivo effects in type II diabetes.
Revers RR, Fink R, Griffin J, Olefsky JM, Kolterman OG. Revers RR, et al. J Clin Invest. 1984 Mar;73(3):664-72. doi: 10.1172/JCI111258. J Clin Invest. 1984. PMID: 6368585 Free PMC article.
Mechanisms of epinephrine-induced glucose intolerance in normal humans.
Saccà L, Vigorito C, Cicala M, Ungaro B, Sherwin RS. Saccà L, et al. J Clin Invest. 1982 Feb;69(2):284-93. doi: 10.1172/jci110451. J Clin Invest. 1982. PMID: 7035494 Free PMC article.

References

1. J Clin Invest. 1949 Mar;28(2):238-44 - PubMed
1. Am J Physiol. 1965 Feb;208:301-6 - PubMed
1. Gastroenterology. 1963 May;44:654-63 - PubMed
1. Am J Physiol. 1954 Dec;179(3):435-8 - PubMed
1. J Clin Invest. 1978 Aug;62(2):425-35 - PubMed

Influence of hyperinsulinemia, hyperglycemia, and the route of glucose administration on splanchnic glucose exchange - PubMed (original) (raw)